By Chris Hutching
Friday 27th October 2000
|Text too small?|
C G Surgical's 10 million shares were issued at 8c recently and Southern Capital bought one million of them. A few early trades last week saw the shares change hands at 60c but this week a parcel of 5000 shares was traded at $1.70.
South Island businessman Mr Paterson, who is a founder shareholder and director of Southern Capital, identified the opportunity to invest in C G Surgical through his links with Otago University researchers.
Other recent fledgling bio-tech companies where Southern Capital has stakes include Blis, which owns patents over a cure for throat infections, and A2 Corporation, which claims patents over milk proteins that may have significance for some health conditions. After initial stagging on Blis and A2 shares issued at 10c, trades have settled to a narrower range around 80c and $2.30, still representing considerable paper profits for Southern Capital.
Managing director Graeme Wong said Southern Capital was retaining its stakes for now.
C G Surgical was developed by engineer Richard Cathro. It has patents over a titanium and teflon clip which prevents pressure on the spinal cord. Pressure can cause neurological-related complaints.
No comments yet
MARKET CLOSE: NZ shares rise in light volume trade, led by Spark, Z; Sky TV falls
NZ dollar little changed near 4-month high, long positions seen capping gains
Bendon posts wider loss despite better sales as Naked merger nears
Govt settles on high-level EQC reforms after five-year long review, eyes 2020 implementation
Woolworths sells EziBuy for undisclosed sum to Sydney investment firm Alceon
Stride Property promotes Philip Littlewood to CEO after six-month spell in joint acting role
Appeal court strikes down Ngatata Love's bid to quash fraud conviction, sentence
Livestock Improvement to lift stake in UK's National Milk Records to 17.2%
NZ King Salmon lifts annual earnings guidance on appetite for fish
Sky TV, Vodafone drop $3.44 billion merger plan, withdraw appeal